Preferred Pharmaceuticals ondansetron ODT recalled for unsealed packs
Preferred Pharmaceuticals is recalling ondansetron ODT 4mg tablets because the blister pack containers are not fully sealed, which can cause tablets to fall out. The manufacturer Glenmark Pharmaceuticals notified Preferred Pharmaceuticals of the sealing defect. This affects specific lot numbers distributed nationwide.
From the FDA notice · Read the official notice ↗ · All Preferred Pharmaceuticals recalls
What to do
- Check if you have ondansetron ODT 4mg tablets from Preferred Pharmaceuticals with lot number J1325J, I1725P, or expiration date 4/30/2027
- Do not use tablets from an unsealed or damaged blister pack
- Dispose of affected tablets safely and contact your pharmacy or doctor for a replacement
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 575 1x10 Foil Blister Packs
- Illnesses reported
- None reported
- Manufactured in
- 1250 N Lakeview Ave Ste O, Anaheim, CA, United States
- Classification
- Class II
- Recall number
- D-0239-2026
In the FDA's words
- Description
- Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01 Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. Lot: J1325J, I1725P, EXP Date: 4/30/2027. Distribution: Natinowide in the USA Affected quantity: 575 1x10 Foil Blister Packs
- Hazard
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
More from Preferred Pharmaceuticals
See all- Preferred Pharmaceuticals eye drops recalled for sterility concerns
ModerateFDAOct 30, 2026
- Preferred Pharmaceuticals Lidocaine Ointment USP 5% recalled for failed content uniformity
ModerateFDAOct 14, 2026